Skip to content

MAZE MAZE Shares (Diluted)

Shares (Diluted) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
256.3M-1.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
44.8M+1.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
63.1M+6.2%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
102.8M+20.3%
Zymeworks logo
ZymeworksZYME
74.7M-0.7%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
110.1M+31.7%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's shares (diluted)?
MAZE (MAZE) reported shares (diluted) of 53.9M in Q1 2026.
How has MAZE's shares (diluted) changed year-over-year?
MAZE's shares (diluted) increased by 88.3% year-over-year, from 28.6M to 53.9M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.